Evidence map›Paper›PMID 39966373›Full record

ArticleNature communications2025

Nitric oxide inhibits ten-eleven translocation DNA demethylases to regulate 5mC and 5hmC across the genome.

Marianne B Palczewski, Hannah Petraitis Kuschman, Brian M Hoffman, Venkatesan Kathiresan, Hao Yang, Sharon A Glynn, David L Wilson, Eric T Kool, William R Montfort, Jenny Chang and 11 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Science advances · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Frontiers in cellular and infection microbiology · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Marianne B PalczewskiDepartment of Pharmaceutical Sciences, University of Illinois Chicago, College of Pharmacy, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-4957-2387
Hannah Petraitis KuschmanDepartment of Pharmaceutical Sciences, University of Illinois Chicago, College of Pharmacy, Chicago, IL, USA.
Brian M HoffmanDepartment of Chemistry, Weinberg College of Arts and Sciences, Northwestern University, Evanston, IL, USA.ORCID http://orcid.org/0000-0002-3100-0746
Venkatesan KathiresanDepartment of Chemistry, Weinberg College of Arts and Sciences, Northwestern University, Evanston, IL, USA.ORCID http://orcid.org/0000-0002-4151-9154
Hao YangDepartment of Chemistry, Weinberg College of Arts and Sciences, Northwestern University, Evanston, IL, USA.
Sharon A GlynnDiscipline of Pathology, University of Galway, College of Medicine, Nursing and Health Sciences, School of Medicine, Galway, Ireland.
David L WilsonDepartment of Chemistry, Stanford University, School of Humanities and Sciences, Stanford, CA, USA.
Eric T KoolDepartment of Chemistry, Stanford University, School of Humanities and Sciences, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-7310-2935
William R MontfortDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ, USA.ORCID http://orcid.org/0000-0001-5776-2530
Jenny ChangDr. Mary and Neal Cancer Center at Houston Methodist, Weill Cornell Medical College, Houston, NY, USA.
Aydolun PetenkayaDepartment of Biomedical Engineering, University of Illinois Chicago, College of Engineering, Chicago, IL, USA.
Constantinos ChronisDepartment of Biochemistry and Molecular Genetics, University of Illinois Chicago, College of Medicine, Chicago, IL, USA.
Thomas R CundariDepartment of Chemistry, University of North Texas, Denton, TX, USA.
Sushma SappaDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, USA.
Kabirul IslamDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, USA.
Daniel W McVicarCancer Innovation Laboratory, National Cancer Institute, Center for Cancer Research, Frederick, MD, USA.ORCID http://orcid.org/0000-0002-1112-5111
Yu FanNational Cancer Institute, Center for Biomedical Informatics and Information Technology, Bethesda, USA.ORCID http://orcid.org/0000-0002-7473-6104
Qingrong ChenNational Cancer Institute, Center for Biomedical Informatics and Information Technology, Bethesda, USA.
Daoud MeerzamanCancer Innovation Laboratory, National Cancer Institute, Center for Cancer Research, Frederick, MD, USA.
Michael SierkCancer Innovation Laboratory, National Cancer Institute, Center for Cancer Research, Frederick, MD, USA.ORCID http://orcid.org/0000-0002-0657-0288
Douglas D ThomasDepartment of Pharmaceutical Sciences, University of Illinois Chicago, College of Pharmacy, Chicago, IL, USA. ddthomas@uic.edu.ORCID http://orcid.org/0000-0003-1252-0786

Funding

Uranium as an Environmental Risk Factor for Cancer Among the NavajoU54CA143924 · NCI · UNIVERSITY OF ARIZONA · PI Jennifer Wright Bea · 2009 to 2026
$26.7M
Coboglobins-Cobalt-Substituted Hemoglobins and MyoglobinR01GM111097 · NIGMS · NORTHWESTERN UNIVERSITY · PI HOFFMAN, BRIAN M · 2014 to 2025
$6.7M
Measuring and Modulating Oxidative DNA Damage Surveillance PathwaysR01CA217809 · NCI · STANFORD UNIVERSITY · PI KOOL, ERIC T. · 2017 to 2024
$3.7M
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)R01CA284315 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI JENNY C-N CHANG · 2023 to 2026
$2.6M
Reprogramming Gene Regulatory Networks to a Hematopoietic Stem Cell StateR01HL170286 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Konstantinos Chronis · 2023 to 2026
$2.1M
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)U01CA268813 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI JENNY C-N CHANG, FUNDA MERIC-BERNSTAM · 2022 to 2026
$2.0M
Crosslinking-Assisted Substrate Identification for Lysine DemethylasesR01GM130752 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ISLAM, KABIRUL · 2020 to 2023
$1.2M
Nitric oxide inhibits Iron(II)2-Oxogluterate dependent demethylases to regulate DNA and mRNA methylationR01GM155946 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI THOMAS, DOUGLAS D. · 2024 to 2025
$901k
National Science Foundation (NSF) CHE-2204114National Science Foundation (NSF) OAC-2117247NCI NIH HHS R01 CA217809NCI NIH HHS R01 CA284315NCI NIH HHS U01 CA268813NCI NIH HHS U54 CA143924NHLBI NIH HHS R01 HL170286NIGMS NIH HHS R01 GM111097NIGMS NIH HHS R01 GM130752NIGMS NIH HHS R01 GM155946Science Foundation Ireland (SFI) 17/CDA/4638U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01GM111097U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01GM130752U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) CA217809U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA284315U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U01CA268813U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM155946
6 · The paper itself

Abstract

DNA methylation at cytosine bases (5-methylcytosine, 5mC) is a heritable epigenetic mark regulating gene expression. While enzymes that metabolize 5mC are well-characterized, endogenous signaling molecules that regulate DNA methylation machinery have not been described. We report that physiological nitric oxide (NO) concentrations reversibly inhibit the DNA demethylases TET and ALKBH2 by binding to the mononuclear non-heme iron atom forming a dinitrosyliron complex (DNIC) and preventing cosubstrates from binding. In cancer cells treated with exogenous NO, or endogenously synthesizing NO, 5mC and 5-hydroxymethylcytosine (5hmC) increase, with no changes in DNA methyltransferase activity. 5mC is also significantly increased in NO-producing patient-derived xenograft tumors from mice. Genome-wide methylome analysis of cells chronically treated with NO (10 days) shows enrichment of 5mC and 5hmC at gene-regulatory loci, correlating with altered expression of NO-regulated tumor-associated genes. Regulation of DNA methylation is distinctly different from canonical NO signaling and represents a unique epigenetic role for NO.

Indexed as

5-MethylcytosineDNA-Binding ProteinsNitric OxideProto-Oncogene ProteinsAnimalsCell Line, TumorDioxygenasesDNA MethylationEpigenesis, GeneticHumansMice5-hydroxymethylcytosine5-MethylcytosineDioxygenasesDNA-Binding ProteinsNitric OxideProto-Oncogene Proteins

Identifiers

PMID39966373
PMCPMC11836389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.